Episodios

  • Diabetologist and Psychologist: How to harness each other's skills?

    Diabetologist and Psychologist: How to harness each other's skills?
    Mar 27 2026
    In this episode, leading experts Maciej T. Małecki, Norbert Hermanns and Dominic Ehrmann explore the essential role of clinical psychology in diabetes care. Living with diabetes, particularly type 1 diabetes, requires constant decision-making and places a significant psychological burden on individuals and their families. From diabetes distress and depression to fear of hypoglycaemia, mental health challenges can directly impact glycaemic control and quality of life. This discussion highlights why clinical psychologists must be integrated into multidisciplinary diabetes teams, the need for specialised “diabetes psychologists,” and how education, guidelines and policy change can help address current gaps in care.
    Más Menos
    11 m
  • The Future of Scientific Publishing: Trust, Transparency and Turbulence

    The Future of Scientific Publishing: Trust, Transparency and Turbulence
    Mar 20 2026
    In this episode, we explore the rapidly evolving world of scientific publishing and the challenges facing researchers today, featuring insights from Diabetologia Editor in Chief Prof. Hindrik Mulder, Maria Hodges, Past EASD Early Career Member Pierre Larraufie and Annette Schürmann. From the rise of predatory journals and paper mills to the growing influence of artificial intelligence, the landscape is becoming increasingly complex. Our experts discuss how open access has reshaped publishing, why peer review remains essential, and the pressures placed on early career researchers navigating where and how to publish. They also explore the limitations of impact factors, the risks of fraudulent data, and the urgent need for new ways to evaluate scientific contribution. Join us for a timely conversation on how the research community can safeguard quality, transparency, and trust in science and what the future of publishing might look like.
    Más Menos
    20 m
  • Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials

    Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials
    Mar 13 2026
    In this episode, Prof. Chantal Mathieu and Prof. Francesco Dotta discuss two major European clinical trials presented at the EASD Annual Meeting: MELD-ATG and VERA-T1D. Both studies were conducted through the INNODIA consortium, a large European collaboration aimed at identifying biomarkers and testing new disease-modifying therapies for type 1 diabetes. The VERA-T1D trial investigated verapamil, a long-established cardiovascular drug, for its potential to preserve beta cell function after diagnosis. While the study narrowly missed its primary endpoint, the results provide important insights into disease heterogeneity and future combination therapies. The MELD-ATG trial used an innovative adaptive trial design to identify an effective low dose of anti-thymocyte globulin (ATG), showing that a single low-dose infusion may help delay beta-cell decline in newly diagnosed patients. Together, these studies highlight the rapid progress being made in type 1 diabetes research and the growing move toward precision medicine approaches.
    Más Menos
    17 m
  • Clinical Guidelines: How To Develop and Bring Into Practice

    Clinical Guidelines: How To Develop and Bring Into Practice
    Mar 6 2026
    In this episode, members of the EASD Committee on Clinical Affairs (CCA) discuss how clinical guidance is developed, reviewed and translated into real-world practice. CCA Chair, Prof. Richard Holt and Prof. Anne Peters explore the production of consensus reports, expert opinion documents and the EASD’s new guideline programme. They discuss the first EASD guideline on diabetes distress, the upcoming guideline on continuous glucose monitoring in type 2 diabetes, and updates to the Type 1 diabetes consensus report. The conversation also highlights the critical role of patient involvement, public consultation and policy engagement in ensuring that guidance improves care across Europe and beyond.
    Más Menos
    12 m
  • Tailored Nutrition and Low-Calorie Diet Remission Updates

    Tailored Nutrition and Low-Calorie Diet Remission Updates
    Feb 27 2026
    In this episode, Prof. Nita Forouhi (University of Cambridge) and Prof. Michael Lean (University of Glasgow) explore the science behind nutrition, weight loss and type 2 diabetes remission. They discuss the role of ultra-processed foods, meat consumption and the importance of whole-food, minimally processed diets. The conversation highlights groundbreaking research showing that substantial, intentional weight loss can reverse type 2 diabetes by reducing fat in organs like the liver, pancreas, and heart, restoring insulin sensitivity and pancreatic function. They also tackle how to communicate evidence-based messages amid a flood of misinformation, and the importance of patient-centred research and guidance for real-world diabetes prevention and remission.
    Más Menos
    17 m
  • Recurrent Severe Hypoglycaemic Events: What to do?

    Recurrent Severe Hypoglycaemic Events: What to do?
    Feb 20 2026
    In this episode, experts from the University of Amsterdam (Prof. J. Hans de Vries), the University of Newcastle (Prof. James A.M. Shaw) and Deakin University (Prof. Jane Speight) explore one of the most feared complications of type 1 diabetes: severe hypoglycaemia. While advances in continuous glucose monitoring and automated insulin delivery have reduced severe episodes by around 40%, they have not eliminated the problem. The discussion examines why technology has limits, the challenges of impaired awareness and when transplantation may be considered for people with recurrent severe hypoglycaemia. The conversation also highlights the profound psychological burden of hypoglycaemia; from trauma and anxiety to the long-term impact of messaging around glucose targets and emphasises the importance of listening to people with diabetes when shaping future care.
    Más Menos
    16 m
  • Dementia in Diabetes - Reasons for Hope or Concern?

    Dementia in Diabetes - Reasons for Hope or Concern?
    Feb 13 2026
    In this episode, Prof. Gill Livingston (University College London) and Prof. Thomas van Sloten (UMC Utrecht) explore the complex relationship between diabetes and dementia. People with diabetes face a higher risk of cognitive decline, particularly those with type 2 diabetes, and as treatment improves and life expectancy increases, dementia is becoming a growing clinical challenge. The discussion examines how diabetes medications, including GLP-1 receptor agonists and SGLT2 inhibitors, may influence cognitive outcomes, the role of lifestyle and vascular risk factors, and why prevention must become central to diabetes care. This episode also highlights the urgent need for clinical trials that include dementia and cognition as primary outcomes.
    Más Menos
    13 m
  • EASD Global Council: Making Diabetes Research & Care Equitable Worldwide

    EASD Global Council: Making Diabetes Research & Care Equitable Worldwide
    Feb 6 2026
    In this episode, Professor Francesco Giorgino (EASD President) and Professor Leszek Czupryniak (EASD Global Council Advisor) introduce EASD's newest initiative: the Global Council, launched in Madrid in 2023. This 13-member council brings together diabetes experts from Asia, North and South America, Africa, the Middle East, Australia, and underrepresented regions of Europe to provide direct, active contributions to EASD activities and address global challenges in diabetes research and care. The conversation addresses the urgent importance of diversity in diabetes data and research, particularly as political movements in some regions actively discourage it and explains how registries are essential for understanding diabetes epidemiology and care delivery across different contexts. Listen in to hear the announcement of a historic milestone: EASD's first new prize in nearly 60 years: the inaugural Global Impact Prize for Diabetes was awarded to Dr. Viswanathan Mohan from India for pioneering work in diabetes epidemiology and subtypes in Asia in 2025. Looking forward, the council is developing global structures for registries, supporting research development in underserved regions, and moving from hopes to concrete solutions.
    Más Menos
    12 m